MENU
KRYS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Krystal Biotech (KRYS) Ownership - Who owns Krystal Biotech?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
2100 Wharton Street
Phone
+1 412 586-5830
Employees
229
Web
https://www.krystalbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.86B
P/E Ratio
94.97
Total Cash
588.32M
Projected Growth
N/A
Total Debt
7.48M
Revenue
241.52M
Risk (Beta)
0.55
Dividend Yield
N/A
Total Cash/Share
20.46
Total Debt/Equity
N/A
Revenue/Share
8.20 USD as % of share price
Fundamentals
KRYS
Capitalization
4.86B
P/E Ratio
94.97
Risk (Beta)
0.55
Dividend Yield
N/A
Total Cash
588M
Total Cash/Share
20.46
Total Debt
7.48M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
8.20%
Revenue
242M
ROE
N/A
Book Value
886M
P/B Ratio
5.49
Cash Flow
N/A
Earnings
1.85
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
7.97
Current Revenue Per Employee
366117.90
Dividends Per Share - Security
N/A
EBITDA
181M
Float
N/A
Float - Current
N/A
Gross Income Margin
92.03
Revenue To Assets
5.91
Shares Held By Institutions
8.48B
Shares Outstanding - Current
28.8M
Total Liabilities
96.5M
Total Volume MTD
N/A
Value
-1
Gain YTD
36.257
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company which provides therapies for rare and orphan diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
2100 Wharton Street
Phone
+1 412 586-5830
Employees
229
Web
https://www.krystalbio.com